Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
- SONAR Committees and Investigators
- University of Groningen
- University of Copenhagen
- Aarhus University
- AbbVie
- The University of Chicago
- National Medical Science and Nutrition Institute Salvador Zubirán
- Southern Medical University
- Wake Forest University
- University of Utah
- Okayama University
- University of Glasgow
- Renal Associates PA
- The George Institute for Global Health
- University of Toronto
Research output: Contribution to journal › Article › peer-review